News from sanofi genzyme
A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages
03 Nov, 2016, 12:20 GMT Pivotal Phase 2/3 Trial of Olipudase Alfa for Adult Patients With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease Type B) to Begin in the UK
Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today that the first adult patient in the UK has enrolled and been dosed ...